Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel in refractory partial seizures (Study 304)
NCT00699972Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2008
- Primary completion
- Oct 2010
- Modality
- Classical Binding Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of perampanel in focal seizures, sponsored by Eisai Co., Ltd.. Started Apr 2008; status: completed.
02
Drugs
perampanel
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00699972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699972.